Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Roberti

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Human Pathology|April 21, 2012
Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancerJ M Arriaga, I A Bravo, L Bruno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variantsM Messaoudene, T P Mourikis, J Michels, et al.
Cell Research|September 5, 2019
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Takahiro Yamazaki, Maria P Roberti, et al.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumorsBertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Nature Communications|September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanomaN Jacquelot, M P Roberti, D P Enot, et al.
Nature Medicine|July 9, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Human Pathology|April 21, 2012
Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancerJ M Arriaga, I A Bravo, L Bruno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variantsM Messaoudene, T P Mourikis, J Michels, et al.
Cell Research|September 5, 2019
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Takahiro Yamazaki, Maria P Roberti, et al.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumorsBertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Nature Communications|September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanomaN Jacquelot, M P Roberti, D P Enot, et al.
Nature Medicine|July 9, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.
Pageof 2